onderzoek Roche’s Tecentriq meets primary endpoint in Phase 3 bladder cancer trial 12 augustus 2019InPharm.com
onderzoek Astellas begins phase 3 trials of fezolinetant in postmenopausal women with vasomotor symptoms 12 augustus 2019Pharma Biz
onderzoek AstraZeneca’s Lynparza meets primary endpoint in Phase 3 prostate cancer trial 12 augustus 2019InPharm.com
wet- en regelgeving European approval for two new delivery formulations of GSK’s Nucala in severe eosinophilic asthma 12 augustus 2019InPharm.com
wet- en regelgeving Sanofi’s Dupixent extended in Europe to cover adolescents in atopic dermatits 12 augustus 2019InPharm.com
wet- en regelgeving EMA committee recommends approval of Merck’s Zerbaxa 3g dose to treat adults with HAP, including VAP 12 augustus 2019Pharma Biz
